LicianPro

Kristen Kluska

Equity research analyst · Cancer Fitzgerald

Earnings calls

1

Nov 16, 2026 – Nov 16, 2026

Stocks asked about

1

Questions

1

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Kristen Kluska asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 43:07
      “I was hoping you could characterize some of the natural history work for us and how well understood these patients are assuming not on any treatment. I know there's heterogeneity, of course, on a patient-by-patient difference, but for the most part, do we see that most patients…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Cancer Fitzgerald rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Kristen Kluska. We do not use licensed rating databases.

No rating action by Cancer Fitzgerald on these stocks in the headlines we store yet.